Sinusitis with nasal polyps linked to increased NO levels
Invasive Fungal Sinusitis
758 Sinusitis
Drug Delivery: Recent findings in drug delivery described by researchers from Center for Environmental Health
Recent developments announced by Accentia Biopharmaceuticals
Accentia Biopharmaceuticals, Inc., describe recent developments
Accentia Biopharmaceuticals Appoints Pharmaceutical and Medical Device Veteran to Board of Directors
Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic...
Accentia Biopharmaceuticals Appoints Pharmaceutical and Medical Device Veteran to Board of Directors
Accentia Biopharmaceuticals, Inc. to Present at the Jefferies Healthcare Conference in New York City on Wednesday, June 27, 2007 at 9:40AM/ET
Accentia Biopharmaceuticals, Inc. to Present at the Jefferies Healthcare Conference in New York City on June 27, 2007 at 9:40AM/ET
Reports from Accentia Biopharmaceuticals, Inc., detail the recent activities
NIAID Supports Research Into Etiology of Fungal-Induced Inflammation in Chronic Sinusitis
Accentia Biopharmaceuticals Reports Fiscal Second Quarter 2007 Financial Results
Accentia Biopharmaceuticals Makes Milestone Payment Based on Fast Tracked Pivotal Phase 3 Study with SinuNase for the Treatment of Chronic Sinusitis
Accentia Biopharmaceuticals, Inc., details recent developments
Accentia Biopharmaceuticals, Inc. Updates Results of Nationwide Testing with CRSFungal Profile: the First Diagnostic Test Available for the...
Biotech News: Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI)
Accentia Biopharmaceuticals, Inc. Updates Results of Nationwide Testing with CRSFungal Profile: The First Diagnostic Test Available for the Confirmation of Chronic Sinusitis
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
